{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:44:30Z","timestamp":1790685870492,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.imlet.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T14:46:49Z","timestamp":1483973209000},"page":"57-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["The dual role of cathelicidins in systemic inflammation"],"prefix":"10.1016","volume":"182","author":[{"given":"Fabiano","family":"Pinheiro da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Cerqueira C\u00e9sar","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imlet.2017.01.004_bib0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.peptides.2012.05.014","article-title":"Antimicrobial peptides: clinical relevance and therapeutic implications","volume":"36","author":"Pinheiro da Silva","year":"2012","journal-title":"Peptides"},{"issue":"12","key":"10.1016\/j.imlet.2017.01.004_bib0010","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.rmed.2012.08.018","article-title":"The effect of human antibacterial peptide LL-37 in the pathogenesis of chronic obstructive pulmonary disease","volume":"106","author":"Jiang","year":"2012","journal-title":"Respir. Med."},{"issue":"10","key":"10.1016\/j.imlet.2017.01.004_bib0015","doi-asserted-by":"crossref","first-page":"e111355","DOI":"10.1371\/journal.pone.0111355","article-title":"1,25-dihydroxyvitamin D3 induces LL-37 and HBD-2 production in keratinocytes from diabetic foot ulcers promoting wound healing: an in vitro model","volume":"9","author":"Gonzalez-Curiel","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.imlet.2017.01.004_bib0020","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/ATVBAHA.113.301851","article-title":"Cathelicidin LL-37 induces angiogenesis via PGE2-EP3 signaling in endothelial cells, in vivo inhibition by aspirin","volume":"33","author":"Salvado","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.imlet.2017.01.004_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00011-005-0062-9","article-title":"Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37","volume":"55","author":"Aarbiou","year":"2006","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.imlet.2017.01.004_bib0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-0625.2012.01459.x","article-title":"Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis","volume":"21","author":"Dombrowski","year":"2012","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.imlet.2017.01.004_bib0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00005-015-0359-5","article-title":"The role of cathelicidin LL-37 in cancer development","volume":"64","author":"Piktel","year":"2016","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"10","key":"10.1016\/j.imlet.2017.01.004_bib0040","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2017.01.004_bib0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/icb.2009.19","article-title":"Differing effects of exogenous or endogenous cathelicidin on macrophage toll-like receptor signaling","volume":"87","author":"Pinheiro da Silva","year":"2009","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.imlet.2017.01.004_bib0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/1541-7786.MCR-08-0326","article-title":"Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells","volume":"7","author":"Coffelt","year":"2009","journal-title":"Mol. Cancer Res.: MCR"},{"issue":"3","key":"10.1016\/j.imlet.2017.01.004_bib0055","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4049\/jimmunol.1402845","article-title":"P2\u00d77 receptor regulates internalization of antimicrobial peptide LL-37 by human macrophages that promotes intracellular pathogen clearance","volume":"195","author":"Tang","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2017.01.004_bib0060","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1167\/iovs.09-3904","article-title":"LL-37 via EGFR transactivation to promote high glucose-attenuated epithelial wound healing in organ-cultured corneas","volume":"51","author":"Yin","year":"2010","journal-title":"Investig. Ophthalmol. Visual Sci."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2017.01.004_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.proghi.2015.06.001","article-title":"The origin, expression, function and future research focus of a G protein-coupled receptor, mas-related Gene X2 (MrgX2)","volume":"50","author":"Wu","year":"2015","journal-title":"Prog. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.imlet.2017.01.004_bib0070","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.1402388","article-title":"Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages","volume":"194","author":"Nakagawa","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.01.004_bib0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20131048","article-title":"Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37","volume":"457","author":"Xhindoli","year":"2014","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.imlet.2017.01.004_bib0080","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"De","year":"2000","journal-title":"J. Exp. Med."},{"issue":"24","key":"10.1016\/j.imlet.2017.01.004_bib0085","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/0008-5472.CAN-12-2359","article-title":"Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer","volume":"72","author":"Ren","year":"2012","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.imlet.2017.01.004_bib0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jdermsci.2014.09.002","article-title":"Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea","volume":"76","author":"Salzer","year":"2014","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.imlet.2017.01.004_bib0095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1189\/jlb.0513304","article-title":"Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human macrophages","volume":"95","author":"Wan","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"12","key":"10.1016\/j.imlet.2017.01.004_bib0100","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.bbamem.2009.12.011","article-title":"Dual functions of the human antimicrobial peptide LL-37-target membrane perturbation and host cell cargo delivery","volume":"1798","author":"Zhang","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"73","key":"10.1016\/j.imlet.2017.01.004_bib0105","doi-asserted-by":"crossref","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"12","key":"10.1016\/j.imlet.2017.01.004_bib0110","doi-asserted-by":"crossref","first-page":"e115474","DOI":"10.1371\/journal.pone.0115474","article-title":"No evidence of pathogenic involvement of cathelicidins in patient cohorts and mouse models of lupus and arthritis","volume":"9","author":"Kienhofer","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.imlet.2017.01.004_bib0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tice.2013.04.003","article-title":"Neutrophils LL-37 migrate to the nucleus during overwhelming infection","volume":"45","author":"Pinheiro da Silva","year":"2013","journal-title":"Tissue Cell"},{"issue":"6","key":"10.1016\/j.imlet.2017.01.004_bib0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.5588\/ijtld.13.0831","article-title":"Cathelicidin and human beta-defensin 2 in bronchoalveolar lavage fluid of children with pulmonary tuberculosis","volume":"18","author":"Cakir","year":"2014","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"6","key":"10.1016\/j.imlet.2017.01.004_bib0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tube.2014.09.007","article-title":"Effect of 1,25-dihydroxy vitamin D3 on cathelicidin expression in patients with and without cavitary tuberculosis","volume":"94","author":"Afsal","year":"2014","journal-title":"Tuberculosis"},{"issue":"5","key":"10.1016\/j.imlet.2017.01.004_bib0130","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.micinf.2013.01.001","article-title":"Cathelicidin LL-37 bloodstream surveillance is down regulated during septic shock","volume":"15","author":"Barbeiro","year":"2013","journal-title":"Microbes Infection\/Institut Pasteur"},{"issue":"6862","key":"10.1016\/j.imlet.2017.01.004_bib0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/35106587","article-title":"Innate antimicrobial peptide protects the skin from invasive bacterial infection","volume":"414","author":"Nizet","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2017.01.004_bib0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4049\/jimmunol.1103196","article-title":"Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia","volume":"189","author":"Kovach","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2017.01.004_bib0145","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.1128\/IAI.01043-06","article-title":"Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection","volume":"74","author":"Bergman","year":"2006","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.imlet.2017.01.004_bib0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000353645","article-title":"Role of the cathelicidin-related antimicrobial peptide in inflammation and mortality in a mouse model of bacterial meningitis","volume":"6","author":"Merres","year":"2014","journal-title":"J. Innate Immun."},{"issue":"Pt. 7","key":"10.1016\/j.imlet.2017.01.004_bib0155","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1099\/jmm.0.070888-0","article-title":"Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy","volume":"63","author":"Honda","year":"2014","journal-title":"J. Med. Microbiol."},{"issue":"4","key":"10.1016\/j.imlet.2017.01.004_bib0160","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/157016207781023947","article-title":"The antimicrobial peptide LL-37 inhibits HIV-1 replication","volume":"5","author":"Bergman","year":"2007","journal-title":"Curr. HIV Res."},{"issue":"5","key":"10.1016\/j.imlet.2017.01.004_bib0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijantimicag.2014.11.003","article-title":"Complexity of antimicrobial peptide regulation during pathogen-host interactions","volume":"45","author":"Wassing","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.imlet.2017.01.004_bib0170","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0006-2015","article-title":"Bacterial evasion of host antimicrobial peptide defenses","volume":"4","author":"Cole","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"2","key":"10.1016\/j.imlet.2017.01.004_bib0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/gt.2012.22","article-title":"Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-\/-) mice","volume":"20","author":"Tai","year":"2013","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.imlet.2017.01.004_bib0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000368304","article-title":"The anti-microbial peptide LL-37\/CRAMP is elevated in patients with liver diseases and acts as a protective factor during mouse liver injury","volume":"91","author":"Wertenbruch","year":"2015","journal-title":"Digestion"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781630219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781630219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T15:20:58Z","timestamp":1601306458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524781630219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":36,"alternative-id":["S016524781630219X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.01.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dual role of cathelicidins in systemic inflammation","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}